Statera BioPharma OverviewStatera BioPharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for STAB.
Quarterly EBIT
-$1.55M
↑ 83.96% YoY
As of Sep 30, 2022
Annual EBIT (TTM)
-$30.89M
↓ 165.36% YoY
Trailing 12 months ending Sep 30, 2022
Statera BioPharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for STAB.
As of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022